CREATE Medicines Secures $122M to Advance CAR-T Therapies for Solid Tumors and Autoimmune Diseases
CREATE Medicines, formerly Myeloid Therapeutics, has raised $122 million to advance its CAR-T therapy pipeline. Co-founded by oncologist Siddhartha Mu...